Two New ^βN-Alkanoyl-5-Hydroxytryptamides with Relevant Antinociceptive Activity

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Neuroscience

Background:

• Novel synthetic routes are crucial for developing new therapeutic agents.
• Understanding the mechanisms of pain perception and modulation is key to pain management.
• 5-hydroxytryptamides are a class of compounds with potential biological activities.

Purpose of the Study:

• To synthesize and characterize two new βN-alkanoyl-5-hydroxytryptamides, C20:0-5HT and C22:0-5HT.
• To evaluate the antinociceptive effects of these novel compounds in thermal and chemical pain models.
• To elucidate the underlying mechanisms of action for the observed antinociceptive activities.

Main Methods:

• Synthesis of C20:0-5HT and C22:0-5HT via a new, efficient route.
• Assessment of antinociception using the hot plate test (thermal pain) and formalin, capsaicin, and glutamate-induced licking tests (chemical pain).
• Pharmacological evaluation using receptor antagonists: naloxone (opioid), atropine (muscarinic), AM251 (cannabinoid CB1), and ondansetron (5-HT3).

Main Results:

• Both C20:0-5HT and C22:0-5HT demonstrated significant antinociceptive effects in all tested pain models.
• The antinociceptive activity was reversed by antagonists of opioid, muscarinic, cannabinoid, and serotoninergic pathways, indicating their involvement.
• Opioid receptor involvement was further supported by reduced efficacy in opioid-tolerant mice.

Conclusions:

• A novel and simplified synthetic route for βN-alkanoyl-5-hydroxytryptamides was established.
• C20:0-5HT and C22:0-5HT exhibit potent antinociceptive properties through complex mechanisms involving multiple neurotransmitter systems.
• These compounds serve as promising scaffolds for developing new analgesics.